Presence of an enlarged pool of MOPC-315-specific cytotoxic T lymphocyte precursors in the thymuses of mice that eradicated a large MOPC-315 tumor as a consequence of low-dose melphalan therapy Mary M. BartikMi-Chung AhnMargalit B. Mokyr Original articles Pages: 143 - 153
Combination treatment using thymosin α1 and interferon after cyclophosphamide is able to cure Lewis lung carcinoma in mice Enrico GaraciAntonio MastinoCartesio Favalli Original articles Pages: 154 - 160
Recombinant interleukin-2 and lymphokine-activated killer cells in renal cancer patients: I. phenotypic and functional analysis of the peripheral blood mononuclear cells Claudio FortisElisabetta FerreroClaudio Rugarli Original articles Pages: 161 - 166
Susceptibility of autologous target cells to lysis by lymphokine-activated effectors from interferon-α-treated chronic myelogenous leukaemia patients Graham PawelecGerhard EhningerFriedrich W. Busch Original articles Pages: 167 - 172
Postoperative active specific immunization in curatively resected colorectal cancer patients with a virus-modified autologous tumor cell vaccine B. LehnerP. SchlagV. Schirrmacher Original articles Pages: 173 - 178
Mechanisms of tumour rejection in the murine DBA/2-SL2 concomitant immunity system Dainius CharaciejusHub F. J. DullensWillem Den Otter Original articles Pages: 179 - 184
A phase II trial of murine monoclonal antibody 17-1A and interferon-γ: Clinical and immunological data Mansoor N. SalehAlbert F. LoBuglioM. B. Khazaeli Original articles Pages: 185 - 190
Analysis of natural killer activity and natural killer cell subsets in patients with bladder cancer Tatsuo MoritaAkihiko TokueNagahiro Minato Original articles Pages: 191 - 194
A multicellular tumor spheroid model of cellular immunity against head and neck cancer Peter G. SacksDorothy L. TaylorStimson P. Schantz Original articles Pages: 195 - 200
The effect of ranitidine on cellular immunity in patients with multiple myeloma Hans Jørgen NielsenHenrik NielsenAage Drivsholm Original articles Pages: 201 - 205